Malnutritional neuropathy under intestinal levodopa infusion

Journal of Neural Transmission

Volumn 119, Issue 3, 2012, Pages 369-372

  Klostermann, Fabian ^a   Jugel, Constanze ^a   Müller, Thomas ^b   Marzinzik, Frank ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b St Joseph's Hospital   (Germany)

Author keywords

Intestinal levodopa infusion; Parkinson's disease; Polyneuropathy

Indexed keywords

AMANTADINE; CABERGOLINE; CARBIDOPA PLUS LEVODOPA; CATECHOL METHYLTRANSFERASE INHIBITOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYANOCOBALAMIN; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; FOLIC ACID; HOMOCYSTEINE; LEVODOPA; PYRIDOXINE; ROTIGOTINE; SELEGILINE;

AGED; ARTICLE; CLINICAL ARTICLE; CYANOCOBALAMIN DEFICIENCY; DISEASE PREDISPOSITION; DRUG DOSE REDUCTION; DRUG INFUSION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FOLIC ACID DEFICIENCY; GEL; HUMAN; LABORATORY TEST; MALE; MALNUTRITION; MALNUTRITIONAL NEUROPATHY; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; POLYNEUROPATHY; PRIORITY JOURNAL; PYRIDOXINE DEFICIENCY; SCREENING; SIDE EFFECT; VITAMIN SUPPLEMENTATION;

AGED; CARBIDOPA; HUMANS; INFUSIONS, PARENTERAL; LEVODOPA; MALE; MALNUTRITION; MIDDLE AGED; NEUROTOXICITY SYNDROMES; PARKINSON DISEASE; POLYNEUROPATHIES;

EID: 84857640129     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-011-0689-3     Document Type: Article

References (16)

1. ET Aasheim D Hofso J Hjelmesaeth R Sandbu 2008 Peripheral neuropathy and severe malnutrition following duodenal switch Obes Surg 18 1640 1643 18463930 10.1007/s11695-008-9539-2
2. JF Aita TR Calame 1972 Peripheral neuropathy secondary to isoniazid-induced pyridoxine deficiency Md State Med J 21 68 70 4353461 1:STN:280:DyaE3s3js1Kjsg%3D%3D
3. A Antonini IU Isaias M Canesi M Zibetti F Mancini L Manfredi M Dal Fante L Lopiano G Pezzoli 2007 Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome Mov Disord 22 1145 1149 17661426 10.1002/mds.21500 (Pubitemid 47067225)
4. AL Dellon ES Dellon PL Tassler RD Ellefson M Hendrickson 2001 Experimental model of pyridoxine (B6) deficiency-induced neuropathy Ann Plast Surg 47 153 160 11506323 10.1097/00000637-200108000-00008 1:STN:280: DC%2BD3MvmtFSqug%3D%3D (Pubitemid 32729871)
5. P Heiser M Teepker JC Möller FM Theisen S Friedel J Hebebrand H Remschmidt 2004 Neuropathy due to hypovitaminosis following excessive weight loss J Am Acad Child Adolesc Psychiatry 43 928 929 15266188 10.1097/01.chi. 0000129220.04681.c1 (Pubitemid 38971715)
6. K Juhasz-Pocsine SA Rudnicki RL Archer SI Harik 2007 Neurologic complications of gastric bypass surgery for morbid obesity Neurology 68 1843 1850 17515548 10.1212/01.wnl.0000262768.40174.33 (Pubitemid 46791400)
7. D Manca G Cossu D Murgia A Molari P Ferrigno E Marcia M Melis 2009 Reversible encephalopathy and axonal neuropathy in parkinson's disease during duodopa therapy Mov Disord 24 2293 2294 19795477 10.1002/mds.22807
8. T Müller K Renger W Kuhn 2004 Levodopa-associated increase of homocysteine levels and sural axonal neurodegeneration Arch Neurol 61 657 660 15148140 10.1001/archneur.61.5.657 (Pubitemid 38637680)
9. Müller T, Jugel C, Ehret R, Ebersbach G, Bengel G, Muhlack S, Klostermann F (2011) Elevation of total homocysteine levels in patients with Parkinson's disease treated with duodenal levodopa/carbidopa gel. J Neural Transm (epub ahead of print)
10. D Nyholm AI Nilsson Remahl N Dizdar R Constantinescu B Holmberg R Jansson SM Aquilonius H Askmark 2005 Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease Neurology 64 216 223 15668416 10.1212/01.WNL.0000149637.70961.4C 1:STN:280:DC%2BD2M%2FktFSnsQ%3D%3D
11. WH Oertel E Wolters C Sampaio S Gimenez-Roldan B Bergamasco M Dujardin DG Grosset G Arnold KL Leenders HP Hundemer A Lledó A Wood P Frewer J Schwarz 2006 Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study Mov Disord 21 343 353 16211594 10.1002/mds.20724
12. DS Saperstein GI Wolfe GS Gronseth SP Nations LL Herbelin WW Bryan RJ Barohn 2003 Challenges in the identification of cobalamin-deficiency polyneuropathy Arch Neurol 60 1296 1301 12975298 10.1001/archneur.60.9.1296 (Pubitemid 37099639)
13. P Thaisetthawatkul ML Collazo-Clavell MG Sarr JE Norell PJ Dyck 2004 A controlled study of peripheral neuropathy after bariatric surgery Neurology 63 1462 1470 15505166 1:STN:280:DC%2BD2crjsVChsw%3D%3D (Pubitemid 39426282)
14. C Toth MS Brown S Furtado O Suchowersky D Zochodne 2008 Neuropathy as a potential complication of levodopa use in Parkinson's disease Mov Disord 23 1850 1859 18785232 10.1002/mds.22137
15. PP Urban I Wellach S Faiss P Layer T Rosenkranz K Knop J Weis 2010 Subacute axonal neuropathy in Parkinson's disease with cobalamin and vitamin B6 deficiency under duodopa therapy Mov Disord 25 1748 1752 20740570 10.1002/mds.23342
16. GA Weber P Sloan D Davies 1990 Nutritionally induced peripheral neuropathies Clin Podiatr Med Surg 7 107 128 2154308 1:STN:280: DyaK3c7kvF2ksw%3D%3D (Pubitemid 20085631)